Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Elicio Therapeutics Inc.

ELTX
Current price
5.2 USD +0.2 USD (+4.00%)
Last closed 5.01 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 54 734 968 USD
Yield for 12 month -12.16 %
1Y
3Y
5Y
10Y
15Y
ELTX
21.11.2021 - 28.11.2021

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node"targeted AMP peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company is also developing ELI-007, a multivalent lymph node"targeted AMP peptide vaccine to target mutant v-raf murine sarcoma viral oncogene homolog B1 gene mutations found in solid tumors; and ELI-008, a multivalent lymph node"targeted AMP peptide vaccine to target p53 hotspot mutations. The company is headquartered in Boston, Massachusetts. Address: 451 D Street, Boston, MA, United States, 02210

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.5 USD

P/E ratio

5.5217

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-1 170 000 USD

Last Year

-1 057 000 USD

Current Quarter

-293 000 USD

Last Quarter

-290 000 USD

Key Figures ELTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 998 000 USD
Operating Margin TTM
PE Ratio 5.5217
Return On Assets TTM -96.8 %
PEG Ratio
Return On Equity TTM -353.02 %
Wall Street Target Price 9.5 USD
Revenue TTM
Book Value -0.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share 0.92 USD
Diluted Eps TTM 0.92 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ELTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ELTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 02.06.2023
Dividend Date

Stock Valuation ELTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 5.5217
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.6058
Price Book MRQ 10.1068

Financials ELTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ELTX

For 52 weeks

2.96 USD 11.45 USD
50 Day MA 4.6 USD
Shares Short Prior Month 39 357
200 Day MA 5.84 USD
Short Ratio 2.57
Shares Short 39 918
Short Percent 0.45 %